Evidence map›Paper›PMID 24722493›Full record

Trial reportDiabetes care2014

Musculoskeletal complications in type 1 diabetes.

Mary E Larkin, Annette Barnie, Barbara H Braffett, Patricia A Cleary, Lisa Diminick, Judy Harth, Patricia Gatcomb, Ellen Golden, Janie Lipps, Gayle Lorenzi and 3 more

Open access · hybridAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Diabetes care, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Observational
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Does hand stiffness reflect internal organ fibrosis in diabetes mellitus?Frontiers in clinical diabetes and healthcare · 2023
    Article
  18. Article
  19. Article
  20. Musculoskeletal complications in patients with diabetes mellitus.The Korean journal of internal medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 2 countries.

Mary E LarkinMassachusetts General Hospital Diabetes Research Center, Harvard University, Boston, MA mlarkin1@partners.org.
Annette BarnieMt. Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Barbara H BraffettThe Biostatistics Center, The George Washington University, Rockville, MD.
Patricia A ClearyThe Biostatistics Center, The George Washington University, Rockville, MD.
Lisa DiminickThe Biostatistics Center, The George Washington University, Rockville, MD.
Judy HarthUniversity of Western Ontario, London, Ontario, Canada.
Patricia GatcombYale School of Medicine, Yale University, New Haven, CT.
Ellen GoldenJoslin Diabetes Center, Boston, MA.
Janie LippsDivision of Diabetes, Endocrinology, & Metabolism, Vanderbilt University, Nashville, TN.
Gayle LorenziDepartment of Medicine, University of California San Diego, La Jolla, CA.
Carol MahonyMassachusetts General Hospital Diabetes Research Center, Harvard University, Boston, MA.
David M NathanMassachusetts General Hospital Diabetes Research Center, Harvard University, Boston, MA.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
George Washington University · USHarvard University · USJoslin Diabetes Center · USMassachusetts General Hospital · USMount Sinai Hospital · CAUniversity of California, San Diego · USVanderbilt University · USWestern University · CAYale University · US

Funding

Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)U01DK094157 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Ionut Bebu, Barbara Halina Braffett · 2011 to 2026
$97.6M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Epidemiology of Diabetes Interventions and Complications Data Coordinating CenterU01DK094176 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI BEBU, IONUT, BRAFFETT, BARBARA HALINA · 2012 to 2022
$30.8M
NCATS NIH HHS UL1 TR000114NCATS NIH HHS UL1 TR000142NIDDK NIH HHS U01 DK094157NIDDK NIH HHS U01-DK-094157NIDDK NIH HHS U01 DK094176NIDDK NIH HHS U01-DK-094176
6 · The paper itself

Abstract

objectiveThe development of periarticular thickening of skin on the hands and limited joint mobility (cheiroarthropathy) is associated with diabetes and can lead to significant disability. The objective of this study was to describe the prevalence of cheiroarthropathy in the well-characterized Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort and examine associated risk factors, microvascular complications, and the effect of former DCCT therapy (intensive [INT] vs. conventional [CONV]) on its development. RESEARCH DESIGN AND

methodsThis cross-sectional analysis was performed in 1,217 participants (95% of the active cohort) in EDIC years 18/19 after an average of 24 years of follow-up. Cheiroarthropathy-defined as the presence of any one of the following: adhesive capsulitis, carpal tunnel syndrome, flexor tenosynovitis, Dupuytren's contracture, or a positive prayer sign-was assessed using a targeted medical history and standardized physical examination. A self-administered questionnaire (Disabilities of the Arm, Shoulder and Hand [DASH]) assessed functional disability.

resultsCheiroarthropathy was present in 66% of subjects (64% of the INT group and 68% of the CONV group; P = 0.1640) and was associated with age, sex, diabetes duration, skin intrinsic fluorescence, HbA1c, neuropathy, and retinopathy (P < 0.005 for each). DASH functional disability scores were worse among subjects with cheiroarthropathy (P < 0.0001).

conclusionsCheiroarthropathy is common in people with type 1 diabetes of long duration (∼30 years) and is related to longer duration and higher levels of glycemia. Clinicians should include cheiroarthropathy in their routine history and physical examination of patients with type 1 diabetes because it causes clinically significant functional disability.

Indexed as

AdultBlood GlucoseCross-Sectional StudiesDiabetes Mellitus, Type 1Diabetic AngiopathiesDisability EvaluationFemaleFollow-Up StudiesHumansJoint DiseasesMaleMiddle AgedMusculoskeletal DiseasesPrevalenceRisk FactorsSurveys and QuestionnairesBlood Glucose

Identifiers

PMID24722493
PMCPMC4067398
OpenAlexW2152995373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.